ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKD 5.36

(-1.83%)

Total Assets Summary of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest annual total assets in 2023 was 874.59 Million CNY , up 4.12% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest quarterly total assets in 2024 Q2 was 743.26 Million CNY , down 0.0% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported annual total assets of 839.97 Million CNY in 2022, down -5.92% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported annual total assets of 892.83 Million CNY in 2021, down 0.0% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported quarterly total assets of 743.26 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported quarterly total assets of 874.59 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Historical Annual Total Assets of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Year Total Assets Total Assets Growth
2023 874.59 Million CNY 4.12%
2022 839.97 Million CNY -5.92%
2021 892.83 Million CNY 0.0%

Peer Total Assets Comparison of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Name Total Assets Total Assets Difference
Uni-Bio Science Group Limited 409.99 Million HKD -113.319%
CK Life Sciences Int'l., (Holdings) Inc. 11.24 Billion HKD 92.224%